EXECUTIVE HEALTH LIMITED

EXECUTIVE HEALTH LIMITED
Contents Page
For the year ended 28 February 2025

Company information	1
Director's report	2
Accountants' report	3
Income statement	4
Statement of financial position	5
Notes to the financial statements	6
Statement of changes in equity	7

EXECUTIVE HEALTH LIMITED
Company Information
For the year ended 28 February 2025

Director	Efua Asare BREW
Registered Number	10640329
Registered Office	298 Holbrook Lane COVENTRY UNITED KINGDOM Coventry, CV6 4DH
Accountants	SA Accountancy Practice Equitable House 10 Woolwich New Road London SE186AB

1

EXECUTIVE HEALTH LIMITED
Director's Report
For the year ended 28 February 2025

Director's report and financial statements

The director presents his/her/their annual report and the financial statements for the year ended 28 February 2025.

Principal activities

Principal activity of the company during the financial year was of
86101 - Hospital activities
86210 - General medical practice activities

Director

The director who served the company throughout the year was as follows:

Efua Asare BREW

Statement of director's responsibilities

The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.

In preparing these financial statements, the director is required to :

select suitable accounting policies and then apply them consistently
make judgements and accounting estimates that are reasonable and prudent
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

On behalf of the board.

----------------------------------
Efua Asare BREW
Director

Date approved: 29 November 2025

2

EXECUTIVE HEALTH LIMITED Accountants' Report For the year ended 28 February 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. SA Accountancy Practice 28 February 2025 .................................................... SA Accountancy Practice Equitable House 10 Woolwich New Road London SE186AB 29 November 2025 3

EXECUTIVE HEALTH LIMITED
Accountants' Report
For the year ended 28 February 2025

Accountant’s report
You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
SA Accountancy Practice
28 February 2025

....................................................

SA Accountancy Practice
Equitable House
10 Woolwich New Road
London
SE186AB
29 November 2025

3

EXECUTIVE HEALTH LIMITED
Income Statement
For the year ended 28 February 2025

	2025 £	2024 £
Turnover	1,096,816	391,473
Cost of sales	(313,591)	(212,304)
Gross profit	783,225	179,169
Selling and distribution costs	-	(2,677)
Administrative expenses	(763,238)	(177,934)
Other operating expenses	-	(2,000)
Operating profit/(loss)	19,987	(3,442)
Interest payable and similar charges	(17,235)	-
Profit/(Loss) on ordinary activities before taxation	2,752	(3,442)
Tax on profit on ordinary activities	-	-
Profit/(Loss) for the financial year	2,752	(3,442)

4

Registered Number: 10640329 EXECUTIVE HEALTH LIMITED
Statement of Financial Position
As at 28 February 2025

	Notes	2025 £	2024 £
Fixed assets
Tangible fixed assets	4	56,000	-
		56,000	-
Current assets
Debtors	5	364,343	121,977
Cash at bank and in hand		2,246	(2,096)
		366,589	119,881
Creditors: amount falling due within one year	6	(60,008)	(81,143)
Net current assets		306,581	38,738

Total assets less current liabilities		362,581	38,738
Creditors: amount falling due after more than one year	7	(363,325)	(39,847)
Provisions for liabilities	8	-	(2,387)
Net assets		(744)	(3,496)

Capital and reserves
Called up share capital		1,000	1,000
Profit and loss account		(1,744)	(4,496)
Shareholders' funds		(744)	(3,496)

For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 29 November 2025 and were signed by:

-------------------------------
Efua Asare BREW
Director

5

EXECUTIVE HEALTH LIMITED
Statement of Changes in Equity
For the year ended 28 February 2025

	Equity share capital	Retained Earnings	Total
	£	£	£
At 01 March 2023	1,000	(54)	946
Profit for the year		(3,442)	(3,442)
Total comprehensive income for the year	-	(3,442)	(3,442)
Dividends		(1,000)	(1,000)
Total investments by and distributions to owners	-	(1,000)	(1,000)
At 29 February 2024	1,000	(4,496)	(3,496)
At 01 March 2024	1,000	(4,496)	(3,496)
Profit for the year		2,752	2,752
Total comprehensive income for the year	-	2,752	2,752
Total investments by and distributions to owners	-	-	-
At 28 February 2025	1,000	(1,744)	(744)

6

EXECUTIVE HEALTH LIMITED
Notes to the Financial Statements
For the year ended 28 February 2025

General Information

EXECUTIVE HEALTH LIMITED is a private company, limited by shares, registered in England and Wales, registration number 10640329, registration address 298 Holbrook Lane, COVENTRY UNITED KINGDOM, Coventry,, CV6 4DH.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Going concern basis

The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Dividends

Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Motor Vehicles

20 Reducing Balance

2.

Staff Costs

	2025 £	2024 £
Wages and salaries	546,022	87,770
Social security costs	47,304	277
Pension costs, defined contribution plan	36,308	895
Other staff costs	13,925	30,696
	643,559	119,638

Average number of employees during the year	Number	Number
Administration	43	11
	43	11

3.	Average number of employees Average number of employees during the year was 43 (2024 : 43).

4.

Tangible fixed assets

Cost or valuation	Motor Vehicles	Total
	£	£
At 01 March 2024	70,000	70,000
Additions	-	-
Disposals	-	-
At 28 February 2025	70,000	70,000
Depreciation
At 01 March 2024	-	-
Charge for year	14,000	14,000
On disposals	-	-
At 28 February 2025	14,000	14,000
Net book values
Closing balance as at 28 February 2025	56,000	56,000
Opening balance as at 01 March 2024	70,000	70,000

5.

Debtors: amounts falling due within one year

	2025 £		2024 £
Other Debtors	-		47,117
	-		47,117

5.

Debtors: amounts falling due after one year

	2025 £	2024 £
Trade Debtors	95,654	-
Other Debtors	268,689	-
Directors Loan Accounts	-	(19,212)
Directors' Loan Accounts	-	94,072
	364,343	74,860

6.

Creditors: amount falling due within one year

	2025 £	2024 £
Trade Creditors	7,319	-
PAYE & Social Security	-	7,431
Wages & Salaries Control Account	-	62,760
Directors' Current Accounts	52,689	10,952
	60,008	81,143

7.

Creditors: amount falling due after more than one year

	2025 £	2024 £
Trade Creditors	363,325	-
Bank Loans & Overdrafts (secured)	-	(2,353)
Other Creditors	-	42,200
	363,325	39,847

8.

Provisions for liabilities

	2025 £		2024 £
Pension Provisions	-		2,387
	-		2,387

7

Registered Number: 10640329
England and Wales
EXECUTIVE HEALTH LIMITED

Unaudited Financial Statements

Period of accounts Start date: 01 March 2024 End date: 28 February 2025